6ZCJ image
Deposition Date 2020-06-11
Release Date 2020-12-02
Last Version Date 2024-11-20
Entry Detail
PDB ID:
6ZCJ
Title:
14-3-3sigma in complex with SLP76pS376 phosphopeptide crystal structure
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.53 Å
R-Value Free:
0.19
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:14-3-3 protein sigma
Gene (Uniprot):SFN
Chain IDs:A
Chain Length:236
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:SLP76pS376
Chain IDs:B (auth: P)
Chain Length:10
Number of Molecules:1
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
The 14-3-3/SLP76 protein-protein interaction in T-cell receptor signalling: a structural and biophysical characterization.
Febs Lett. 595 404 414 (2021)
PMID: 33159816 DOI: 10.1002/1873-3468.13993

Abstact

The SH2 domain-containing protein of 76 kDa, SLP76, is an important adaptor protein that coordinates a complex protein network downstream of T-cell receptors (TCR), ultimately regulating the immune response. Upon phosphorylation on Ser376, SLP76 interacts with 14-3-3 adaptor proteins, which leads to its proteolytic degradation. This provides a negative feedback mechanism by which TCR signalling can be controlled. To gain insight into the 14-3-3/SLP76 protein-protein interaction (PPI), we have determined a high-resolution crystal structure of a SLP76 synthetic peptide containing Ser376 with 14-3-3σ. We then characterized its binding to 14-3-3 proteins biophysically by means of fluorescence polarization and isothermal titration calorimetry. Furthermore, we generated two recombinant SLP76 protein constructs and characterized their binding to 14-3-3. Our work lays the foundation for drug design efforts aimed at targeting the 14-3-3/SLP76 interaction and, thereby, TCR signalling.

Legend

Protein

Chemical

Disease

Primary Citation of related structures